BioAtla (BCAB) Profit After Tax (2020 - 2026)
BioAtla's (BCAB) quarterly Profit After Tax came in at -$6.3 million in Q1 2026, up 58.63% year-on-year from -$4.0 million in Q1 2025, and up 35.16% quarter-over-quarter from -$9.8 million in Q4 2025.
BioAtla (BCAB) Profit After Tax (2020 - 2026) Analysis & Trends
BioAtla's Profit After Tax history runs 7 years deep, the most recent figure standing at -$6.3 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 58.63% year-over-year to -$6.3 million in Q1 2026; TTM through Mar 2026 was -$50.6 million, a 18.2% increase from a year earlier, with the FY2025 full-year figure at -$59.6 million, up 14.57% from the prior year.
- Profit After Tax grew to -$6.3 million in Q1 2026 per BCAB's latest filing, from -$9.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$6.3 million in Q1 2026 and bottomed at -$35.8 million in Q2 2023.
- The 5-year median for Profit After Tax is -$23.2 million (2024), against an average of -$21.5 million.
- Across the five-year window, Profit After Tax soared 68.23% in 2024 and tumbled 49.05% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$27.5 million in 2022, then rose by 2.24% to -$26.9 million in 2023, then jumped by 44.72% to -$14.9 million in 2024, then soared by 34.26% to -$9.8 million in 2025, then jumped by 35.16% to -$6.3 million in 2026.
- Per Business Quant, the three latest BCAB Profit After Tax figures stand at -$6.3 million (Q1 2026), -$9.8 million (Q4 2025), and -$15.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | -6.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.34 Mn |
| Dec 31, 2025 | -9.78 Mn |
| Sep 30, 2025 | -15.78 Mn |
| Jun 30, 2025 | -18.71 Mn |
| Mar 31, 2025 | -15.33 Mn |
| Dec 31, 2024 | -14.88 Mn |
| Sep 30, 2024 | -10.59 Mn |
| Jun 30, 2024 | -21.07 Mn |
| Mar 31, 2024 | -23.23 Mn |
| Dec 31, 2023 | -26.93 Mn |
| Sep 30, 2023 | -33.33 Mn |
| Jun 30, 2023 | -35.75 Mn |
| Mar 31, 2023 | -27.46 Mn |
| Dec 31, 2022 | -27.54 Mn |
| Sep 30, 2022 | -25.78 Mn |
| Jun 30, 2022 | -28.91 Mn |
| Mar 31, 2022 | -24.25 Mn |
| Dec 31, 2021 | -23.39 Mn |
| Sep 30, 2021 | -22.93 Mn |
| Jun 30, 2021 | -30.38 Mn |